Abstract
A 23-year-old girl affected by Papillon-Lefevre syndrome developed, during Etretinate therapy (1 mg/kg/day), two liver abscesses caused by pyogenic bacteria and a subphrenic abscess. The immunological effects of retinoids may precipitate severe infections in patients with Papillon-Lefevre syndrome, who probably have a basic, even though not always evident, defect of PMN chemotaxis.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 148-150 |
| Number of pages | 3 |
| Journal | Dermatology |
| Volume | 176 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 1 1988 |
| Externally published | Yes |
Keywords
- Etretinate
- Liver abscesses
- Papillon-Lefévre syndrome
- Severe infections
ASJC Scopus subject areas
- Dermatology
Fingerprint Dive into the research topics of 'Is etretinate dangerous in papillon-lefévre syndrome?'. Together they form a unique fingerprint.
Cite this
Tosti, A., Manuzzi, P., Bardazzi, F., & Costa, A. (1988). Is etretinate dangerous in papillon-lefévre syndrome? Dermatology, 176(3), 148-150. https://doi.org/10.1159/000248692